Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe

Kissling, Esther ; Rondy, Marc and I-MOVE/I-MOVE+ study team (incl. G.Gefenaite) (2017) In Eurosurveillance 22(7). p.1-9
Abstract
We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65–79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).
Please use this url to cite or link to this publication:
author
; and
contributor
LU orcid
publishing date
type
Contribution to journal
publication status
published
in
Eurosurveillance
volume
22
issue
7
pages
1 - 9
publisher
European Centre for Disease Prevention and Control (ECDC)
external identifiers
  • scopus:85014105621
ISSN
1560-7917
DOI
10.2807/1560-7917.ES.2017.22.7.30464
project
Infectious diseases surveillance, vaccine effectiveness and determinants of acceptance
language
English
LU publication?
no
id
5b462a95-4bb0-466c-9be4-4c4a63baf833
date added to LUP
2023-02-02 10:45:42
date last changed
2023-02-03 04:06:18
@article{5b462a95-4bb0-466c-9be4-4c4a63baf833,
  abstract     = {{We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65–79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).}},
  author       = {{Kissling, Esther and Rondy, Marc and I-MOVE/I-MOVE+ study team (incl. G.Gefenaite)}},
  issn         = {{1560-7917}},
  language     = {{eng}},
  month        = {{02}},
  number       = {{7}},
  pages        = {{1--9}},
  publisher    = {{European Centre for Disease Prevention and Control (ECDC)}},
  series       = {{Eurosurveillance}},
  title        = {{Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe}},
  url          = {{http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464}},
  doi          = {{10.2807/1560-7917.ES.2017.22.7.30464}},
  volume       = {{22}},
  year         = {{2017}},
}